Corrigendum to “Endplate chondrocyte-derived exosomal miR-128-3p mitigates intervertebral disc degeneration by targeting TRAF6 via the miR-128-3p/TRAF6 axis to suppress pyroptosis” [Int. Immunopharmacol. 143(Part 3) (2024) 113620]
International Immunopharmacology · 2026-05 · 177 · 116512
DOI: 10.1016/j.intimp.2026.116512 ↗Kurz gefasst
Korrektur in der Zeitschrift International Immunopharmacology, 2026-05. Verfasst von Qiuwei Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Spine Surgery, the First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, Anhui 230022, China; La…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Orthopedics and Spine Surgery, the First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, Anhui 230022, China; Laboratory of Spinal and Spinal Cord Injury Regeneration and Repair, the…
- Spinal Surgery Division of Yijishan Hospital and Wannan Medical College in Wuhu, Anhui 241000, China.
Zitieren
APA
Li, Q., Guo, R., Wu, Z., Zhao, C., Chen, X., Wang, H., & Shen, C. (2026). Corrigendum to “Endplate chondrocyte-derived exosomal miR-128-3p mitigates intervertebral disc degeneration by targeting TRAF6 via the miR-128-3p/TRAF6 axis to suppress pyroptosis” [Int. Immunopharmacol. 143(Part 3) (2024) 113620]. International Immunopharmacology, 177, 116512. https://doi.org/10.1016/j.intimp.2026.116512
Vancouver
Li Q, Guo R, Wu Z, Zhao C, Chen X, Wang H, et al. Corrigendum to “Endplate chondrocyte-derived exosomal miR-128-3p mitigates intervertebral disc degeneration by targeting TRAF6 via the miR-128-3p/TRAF6 axis to suppress pyroptosis” [Int. Immunopharmacol. 143(Part 3) (2024) 113620]. International Immunopharmacology. 2026;177:116512. doi:10.1016/j.intimp.2026.116512
BibTeX
@article{Li2026,
author = {Li, Qiuwei and Guo, Ruocheng and Wu, Zuomeng and Zhao, Chenhao and Chen, Xuewu and Wang, Hong and Shen, Cailiang},
title = {Corrigendum to “Endplate chondrocyte-derived exosomal miR-128-3p mitigates intervertebral disc degeneration by targeting TRAF6 via the miR-128-3p/TRAF6 axis to suppress pyroptosis” [Int. Immunopharmacol. 143(Part 3) (2024) 113620]},
journal = {International Immunopharmacology},
year = {2026},
volume = {177},
pages = {116512},
doi = {10.1016/j.intimp.2026.116512}
}
EUVIMED